Subject: RE: Revised - with proposed two targeted small meetings
From: "Graeme Robertson" <[email-masked]>
To: Barbara Bulc; Betty Chiang; David Sergeenko
Cc: Ahmed Afifi; [email-masked]; [email-masked]; Dennis Israelski; Clifford Samuel
Date: Thu, 27 Apr 2017 08:08:21 +0000

Dear Barbara,

Please find below the e-mail address for Minister of Health for Georgia Mr David Seergenko

[email-masked]

Please let me know if you need any further information.

Best wishes

Graeme

Graeme.A Robertson

Senior Director,  Africa & CIS

Access Operations & Emerging Markets

--------------------------------------------------------------------------------------------------------------------------------------------------

Gilead Sciences Europe Ltd
• Registered as a limited company in England and Wales • Registered number
05510315

Registered office:
South Building • 2 Roundwood Avenue • Stockley Park • Uxbridge • UB11 1AZ • England

Telephone:
+44(0)208 587 2228
• Mobile: +44(0)7789 268 043 • Fax:
+44(0)208 744 6773

From: Barbara Bulc [mailto:[email-masked]]

Sent: 26 April 2017 23:01

To: Betty Chiang

Cc: Ahmed Afifi; [email-masked]; [email-masked]; Dennis Israelski; Graeme Robertson; Clifford Samuel

Subject: RE: Revised - with proposed two targeted small meetings

Hi Betty and all,

Thanks for productive call. As promised, revised proposal – with some minor changes of language, as discussed, and updated agenda.

Please review and let me know if there are any other changes you’d like to make – and we can do this right away tomorrow.

I will get back to you tomorrow re suggested funding options to speed this up, and address any compliance issues.

Best regards,

Barbara

Barbara Bulc, President

162, Rt. de la Capite, 1244 Geneva, Switzerland

EU tel : +41 79 263 9627

US tel : +1 646 202 1464

[email-masked]

www.globaldevelopment-impact.org

From: Betty Chiang [mailto:[email-masked]]

Sent: 26. april 2017 1:46

To: Barbara Bulc

Cc: Ahmed Afifi; [email-masked];
[email-masked]; Dennis Israelski; Graeme Robertson; Clifford Samuel

Subject: RE: Revised - with proposed two targeted small meetings

Hi Barbara,

Would it be possible to have a teleconference call tomorrow at 9 am PST, which will be 6 pm your time in Geneva? If this time is too late, I can also arrange to speak at 11 pm tonight, 8 am tomorrow
your time.

It would be productive to review the proposal and discuss internal logistics needed to turn this around quickly.

Thanks so much.

Betty

Betty Chiang, M.D.

Senior Director, Public Health & Medical Affairs

Access Operations & Emerging Markets

Gilead Sciences, Inc.

Office: +1-650-522-6132

From: Barbara Bulc [mailto:[email-masked]]

Sent: Tuesday, April 25, 2017 2:14 AM

To: Clifford Samuel

Cc: Betty Chiang; Ahmed Afifi; [email-masked];
[email-masked]

Subject: RE: Revised - with proposed two targeted small meetings

Clifford,

Trust you had a great weekend. Time to speak today how you’d like to proceed?

Best regards,

Barbara

From: Barbara Bulc [mailto:[email-masked]]

Sent: 21. april 2017 17:37

To: 'Clifford Samuel'

Cc: 'Betty Chiang'; 'Ahmed Afifi'; Anand Reddi ([email-masked]);
[email-masked]; Kaitlyn Perreault <[email-masked]> ([email-masked]); [email-masked]'

Subject: RE: Revised - with proposed two targeted small meetings

Clifford –

FYI, this is timely, in case you have not seen it.

Released by WHO today -
new hepatitis data highlight need for urgent global response:

http://who.int/mediacentre/news/releases/2017/global-hepatitis-report/en/?utm_source=WHO+List&utm_campaign=468894c6ad-EMAIL_CAMPAIGN_2017_04_20&utm_medium=email&utm_term=0_823e9e35c1-468894c6ad-228936873

Best regards, Barbara

From: Barbara Bulc [mailto:[email-masked]]

Sent: 21. april 2017 15:01

To: 'Clifford Samuel'

Cc: 'Betty Chiang'; 'Ahmed Afifi'; Anand Reddi ([email-masked]);
[email-masked]; Kaitlyn Perreault <[email-masked]> ([email-masked]); [email-masked]'

Subject: RE: Revised - with proposed two targeted small meetings

Clifford -

For your consideration and feedback, here is revised proposal with proposed two focused intimate meetings at MOH/deputy level.

Details with objectives, format and suggested participants are included (highlighted in
green).

Important would be to get to an agreement on action plan after the meeting.

In short -- to maximize the opportunity, I suggest:

·
the first meeting  focused on Nigeria MOH, with India or another high profile country (and other very select individuals to leverage and get high level MOH participation - WHO Hep lead, GFATM and UNITAID, World
Hep Alliance and Gilead with Abbott), in English. Here ideally we should consider focusing on states that have interest and good leadership, we can advise.

·
the second one, with MOH Gabon, Cameroon, leveraged with France and AFD - along with others (as above), preferably in French re Gabon.

These two would be ideally organized as dinner meetings either on Sun, Mon or Tue 6:30 pm - 8:00pm (note that WHO Executive Director elections are scheduled for Tuesday, so Tuesday would be the best time for us – if
possible), we would need to play around depending on Ministers availability/ arrival/departures.

Feel free to call me when you can - or lets plan to speak on Monday. We would need to make a decision on Monday or at the latest on Tuesday to make this happen.

Thank you, and wish you a nice weekend.

Barbara

-----Original Message-----

From: Clifford Samuel [mailto:[email-masked]]

Sent: 20. april 2017 15:59

To: Barbara Bulc

Cc: [email-masked];
[email-masked]; Betty Chiang; Ahmed Afifi

Subject: Re: Revised proposal with proposed agenda - for your feedback

Barbara - one or two smaller, intimate meetings would be good - this way we can really get to the nuts and bolts of  the Viral Hepatitis situation in country and what's possible given that new DAAs have altered the
landscape considerably.

> On Apr 20, 2017, at 3:25 PM, Barbara Bulc <[email-masked]> wrote:

>

> Clifford,

>

> Very good to speak, great feedback.

> I strongly agree with you that a more intimate setting and focused

> conversation with Nigeria, Gabon, Cameroon are good way to go.

> Perhaps even two separate small dinner meetings, depending on availability

> of the ministers while in Geneva.

>

> We'll update the proposal and send it to you today for feedback.

> We should aim to make final decision on Monday.

>

> Enjoy your weekend,

> Barbara

>

> -----Original Message-----

> From: Clifford Samuel [mailto:[email-masked]]

> Sent: 20. april 2017 13:19

> To: Barbara Bulc

> Subject: Re: Revised proposal with proposed agenda - for your feedback

>

> Ok.

>

>> On Apr 20, 2017, at 12:00 PM, Barbara Bulc <[email-masked]> wrote:

>>

>> Great. Best you call me when you are finished, I am in the office.

>>

>> What is not in the proposal - but we should think of - is setting up 1:1

>> meetings with Nigeria and Gabon, or any other you may be interested.

>> Let's discuss. High level delegates with Ministers are here usually day

> 1-2,

>> may arrive already on Sunday.

>>

>> Speak soon, Barbara

>>

>> -----Original Message-----

>> From: Clifford Samuel [mailto:[email-masked]]

>> Sent: 20. april 2017 11:32

>> To: Barbara Bulc

>> Cc: Jos Perriens;
[email-masked]

>> Subject: Re: Revised proposal with proposed agenda - for your feedback

>>

>> Barbara - thanks for this - will review.  Please ring around 2:15....have

>> another call at 1:45 that could run pass 2.  Thx

>>

>> On Apr 20, 2017, at 10:44 AM, Barbara Bulc

>> <[email-masked]<mailto:[email-masked]>> wrote:

>>

>>

>> Clifford

>>

>> This is excellent! I included Abbott in the draft agenda.

>>

>>

>>

>> Here is our revised proposal, for the WHA event only and focused on

> Nigeria,

>> Gabon, Cameroon. Highlighted in yellow are all changes made.

>>

>> *         On page 4 - is a more detailed outline of the event, for your

>> feedback and suggestions, page 5 has activities and budget.

>>

>> *         Possible title - you may have better suggestion and we can

>> discuss:

>>

>> New Opportunities To Eliminate Viral Hepatitis - Access Strategies for

>> Prevention, Diagnostics and Treatment

>>

>>

>>

>> We quickly checked possible venues - Hotel Intercontinental would be the

>> best choice, they will try to find something for May 22 or 23 (first two

>> days), approx. 50 people max.

>>

>> They will let us know today.

>>

>>

>>

>> Looking forward to speak at 2pm, will call you then.

>>

>> Best regards, Barbara

>>

>>

>>

>>

>>

>>

>>

>>

>>

>> -----Original Message-----

>> From: Clifford Samuel [mailto:[email-masked]]

>> Sent: 20. april 2017 7:15

>> To: Barbara Bulc

>> Cc: Jos Perriens

>> Subject: Re: Geneva next week - Hep C meeting follow up

>>

>>

>>

>> Barbara - had a chat with Gavin from Abbott Diagnostics yesterday - he's

>> open to joining a discussion - let's chat later.

>>

>>

>>

>> CMS

>>

>>

>>

>>> On Apr 18, 2017, at 3:49 PM, Barbara Bulc

>> <[email-masked]<mailto:[email-masked]>> wrote:

>>

>>

>>> Ok. Please call when you are free to speak.

>>

>>> Barbara

>>

>>

>>> Sent from my iPhone

>>

>>

>>>> On 18 Apr 2017, at 11:51, Clifford Samuel

>> <[email-masked]<mailto:[email-masked]>> wrote:

>>

>>

>>>> After 2pm works

>>

>>

>>>>> On Apr 18, 2017, at 10:38 AM, Barbara Bulc

>> <[email-masked]<mailto:[email-masked]>> wrote:

>>

>>

>>>>> Great, thanks Clifford. Anytime after 2pm is good, I am traveling but

> on

>> my cell.

>>

>>

>>>>> Note that Gabon and Nigeria are currently not on UNITAID / WHO

>> diagnostic 38M grant list which means this may give us less political

>> leverage in certain circles. For consideration and sth to discuss further.

>>

>>

>>>>> Any preferred time for you today?

>>

>>>>> Best regards,

>>

>>>>> Barbara

>>

>>

>>>>> Sent from my iPhone

>>

>>

>>>>>> On 18 Apr 2017, at 08:29, Clifford Samuel

>> <[email-masked]<mailto:[email-masked]>> wrote:

>>

>>

>>>>>> Barbara - greetings from London - have periodic times today for a

> chat.

>> Talked to the team where countries are concerned and Gabon and Nigeria are

>> two countries of interest.

>>

>>

>>>>>> CMS

>>

>>

>>>>>> On Apr 14, 2017, at 4:05 PM, Barbara Bulc

>>

> <[email-masked]<mailto:[email-masked]<mailto:[email-masked]%3

>> cmailto:[email-masked]>>> wrote:

>>

>>

>>

>>>>>> Clifford,

>>

>>

>>

>>

>>>>>> Thanks for your message. Yes, I think it is still feasible but let's

>> discuss together as soon as possible.

>>

>>

>>>>>> Several side meetings are still in preparations at this time.

>>

>>

>>

>>

>>>>>> Specifically, lets speak in more detail about:

>>

>>

>>>>>> *         your preferred focus countries

>>

>>

>>>>>> *         key objectives, agenda and targeted outreach

>>

>>

>>>>>> *         date and possible venue

>>

>>

>>

>>

>>

>> <Revised GD_Proposal_Hep C Market Development _WHA Event Only_April19.pdf>

>>

>>

>>

>

>

>

DISCLAIMER If you have received this message in error, please contact the sender immediately by return e-mail and notify the sender and then delete this message (including any attachments) from your system. This communication and any attachments contain information
which is confidential and may also be legally privileged. It is for the exclusive use of the intended recipient(s). If you are not the intended recipient(s) please note that any form of disclosure, distribution, copying or use of this communication or the
information in it or in any attachments is strictly prohibited and may be unlawful. E-mail communications cannot be guaranteed to be secure or error free, as information could be intercepted, corrupted, amended, lost, destroyed, arrive late or incomplete,
or contain viruses. Gilead does not accept liability for any such matters or their consequences. Anyone who communicates with Gilead by e-mail is taken to accept the risks in doing so. Gilead has taken every reasonable precaution to ensure that any attachment
to this e-mail has been swept for viruses. However, Gilead cannot accept liability for any damage sustained as a result of viruses and would advise that you carry out your own virus checks before opening any attachment. Gilead Sciences Europe Ltd ; Registered
as a limited company in England and Wales ; Registered number 5510315 Registered office: South Building ; 2 Roundwood Avenue ; Stockley Park ; Uxbridge ; UB11 1AF ; England